Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders

Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders

US Patent 8987200 · Granted Mar 24, 2015

Estimated economic value: $51,536,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating headache comprising administering an antibody to calcitonin gene-relate2023
Antagonist antibodies directed against calcitonin gene-related peptide and metho2020
Treating headache comprising administering an antibody to calcitonin gene-relate2019
Therapeutic agents for reducing parathyroid hormone levels2019
Antagonist antibodies directed against calcitonin gene-related peptide and metho2018
Therapeutic agents for reducing parathyroid hormone levels2017
Therapeutic agents for reducing parathyroid hormone levels2017
Therapeutic agents for reducing parathyroid hormone levels2016
Therapeutic agents for reducing parathyroid hormone levels2015
Therapeutic agents for regulating serum phosphorus2015
Therapeutic agents for regulating serum phosphorus2015
Therapeutic agents for reducing parathyroid hormone levels2013